iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) Stock Quotes and News | Benzinga

Market Overview

106.38 0 (0%)

Data as of May 22, 2018

Prev. Close 106.38
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg. 106.24
PE Ratio 0
Shares Outstanding
Market Cap

Trade IBB stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Dova Receives FDA Nod For Bleeding Disorder Treatment; Rival Drug Awaits Clearance Shanthi RexalineMon, 21 May 2018 13:17:19 -0400
The Week Ahead In Biotech: PDUFA Dates, IPOs And More Shanthi RexalineMon, 21 May 2018 07:40:56 -0400
Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved Shanthi RexalineFri, 18 May 2018 08:00:30 -0400
Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More Shanthi RexalineThu, 17 May 2018 08:27:58 -0400
CNBC Reports 'The Bezos-Buffett joint venture to save health care is struggling to find a CEO' Benzinga NewsdeskWed, 16 May 2018 13:08:18 -0400
Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings Shanthi RexalineWed, 16 May 2018 08:10:54 -0400
Analyst: Trump's 'Naming And Shaming' Campaign To Build Pharma Headline Risk Elizabeth BalboaTue, 15 May 2018 09:55:44 -0400
Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway Shanthi RexalineTue, 15 May 2018 08:44:25 -0400
Gilead, Match Group, Biotech, Ethereum: 'Fast Money' Picks For May 14 Craig JonesMon, 14 May 2018 07:13:54 -0400
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More Shanthi RexalineSun, 13 May 2018 10:06:03 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Strongbridge Biopharma plc Added to the NASDAQ Biotech Index Globe NewswireDec 13, 2017
Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index Business WireDec 11, 2017
BlackRock Announces Share Split for iShares Nasdaq Biotechnology ETF Business WireNov 07, 2017
MediciNova Added to NASDAQ Biotechnology Index Globe NewswireDec 14, 2016
Blueprint Medicines Added to NASDAQ Biotechnology Index PRNewswireDec 17, 2015
Collegium Added to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
Vitae Pharmaceuticals Announces Addition to the NASDAQ Biotechnology Index Globe NewswireDec 14, 2015
GW Pharmaceuticals Added to NASDAQ Biotechnology Index Globe NewswireDec 22, 2014
Revance Therapeutics Added to NASDAQ Biotechnology Index Globe NewswireDec 18, 2014
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) Globe NewswireDec 18, 2014
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

REITs trade up as LaSalle Hotel takeover battle highlights category Seeking Alpha14 hours ago
REITs trade up as LaSalle Hotel takeover battle highlights category Seeking Alpha14 hours ago
Investors bullish on biotechs after Trump drug pricing speech Seeking Alpha3 days ago
Rounds Report: Eiger Moved Northbound While Spectrum Rallied Strongly Due To ADVANCE Trial Results Seeking Alpha4 days ago
Rounds Report: The Eleven Train Is Increasing Speed Toward Its May 21 Clinical Binary Seeking Alpha4 days ago
On The Move: Viking Therapeutics Seeking Alpha4 days ago
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)? Zacks4 days ago
Profit From Rising Consumer Spending And Household Debt Seeking Alpha5 days ago
The Failure Of The ETF Phenomenon: 20 Years Of History, And The Market Has Spoken Seeking Alpha5 days ago
Rounds Report: Omeros Rallied Robustly While Stellar FDA Due Diligence To Help Orphan Disease Innovators Seeking Alpha5 days ago
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Brokerage Center

Compare All Online Brokerages